COVID-19 Vaccine Trial Data from Pfizer Likely Delayed

November 3, 2020

COVID-19 Vaccine Trial Data from Pfizer Likely Delayed

Although Pfizer started clinical trials with a goal of releasing data by the beginning of November, that has become unlikely. CEO Albert Bourla announced that the company doesn’t anticipate sharing information on its trial until about a week after the data and safety monitoring board conducts its review of the company’s phase three vaccine trial. Yourway has two decades of experience and a robust global footprint, which allows us to deliver faster turnaround times.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Keeping trials on track: Prioritizing communication in decentralized trials

Open chat

Hello! How can I help you?